FRAMOSA CO., LTD.
Update：2026/09/15
Industries
Main Industry
Sustainability
Main Product/Service
1. Pharmaceutical Raw Material Solvent Recovery and Treatment
2. Wastewater Recovery and Treatment
(The content above was translated by AI.)
2. Wastewater Recovery and Treatment
(The content above was translated by AI.)
Founded Year
2020
Unified Business No.
83138255
Status
Active
Number of Employees
0
Total Paid-in
Capital
725,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
FRAMOSA CO., LTD. is a joint venture in Taiwan between Veolia Group, the largest environmental group in France, Mercuries & Associates Holding, and SciPharmtech Inc. As a pharmaceutical raw material solvent recovery plant, FRAMOSA CO., LTD. will process waste solvents (methanol, ethanol, acetone, ethyl acetate, isopropyl alcohol, toluene, acetonitrile, and hexane) from active pharmaceutical ingredient (API) manufacturers in Taiwan, with an annual processing capacity of 23,000 tons. The plant will recover solvents from contracted clients. FRAMOSA CO., LTD. also provides on-site services to pharmaceutical plants, operating by providing the required steam and compressed air, and is responsible for the operation and maintenance of chillers and cooling towers.
(The content above was translated by AI.)
(The content above was translated by AI.)
